IL6 and 22q11.2 deletion syndrome: Vergaelen et al. reported increased Th17 cell levels in 22q11DS individuals with neuropsychiatric symptoms, suggesting that IL-6-mediated Th17 activation may contribute to the development of psychosis and cognitive impairments in this population (Vergaelen et al., 2018).